Composition for improving intestinal environment

A dietary fiber and anthocyanin compound composition effectively improves the balance of intestinal bacteria by promoting bifidobacteria proliferation, addressing the inadequacies of previous compositions.

JP2024163819AInactive Publication Date: 2024-11-22MORISHITA JINTAN CO LTD +2
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
JP2023079727
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-12
Publication Date
2024-11-22
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing compositions for improving intestinal flora diversity do not adequately enhance the balance of intestinal bacteria, particularly the occupancy rate of beneficial bifidobacteria.

Method used

A composition containing water-soluble dietary fiber, such as guar gum decomposition products, combined with anthocyanin compounds from blackcurrant or bilberry extracts, which are easily ingestible and promote the proliferation of bifidobacteria.

Benefits of technology

The combination significantly increases the occupancy rate of bifidobacteria in the intestinal flora and enhances overall bacterial balance, as demonstrated by a randomized, double-blind study.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024163819000002
    Figure 2024163819000002
  • Figure 2024163819000003
    Figure 2024163819000003
  • Figure 2024163819000001
    Figure 2024163819000001
Patent Text Reader

Abstract

To provide a composition for improving intestinal environment that allows easy consumption and can further enhance the balance of intestinal bacteria constituting the intestinal bacterial flora.SOLUTION: A composition for improving intestinal environment contains dietary fiber and an anthocyanin compound. The inventive composition can enhance the balance of the intestinal bacterial flora within a host who has consumed the composition by, for example, increasing the proportion of bifidobacteria within the intestinal bacterial flora. Such a composition is useful as formulations or components for oral consumption, such as supplements, functional health foods, or pharmaceuticals.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a composition for improving intestinal environment, and more specifically to a composition for improving intestinal environment that can improve the balance of intestinal bacteria that constitute the intestinal flora. [Background technology]

[0002] A wide variety of intestinal bacteria are tightly packed in the large intestine, and such a mass is called, for example, intestinal flora or intestinal flora. In addition, in the intestinal flora, a variety of bacteria are formed in the human body, and the balance of the population is maintained, and it is considered important to maintain the balance by increasing the population of good bacteria. For this reason, in recent years, there has been an increasing need to improve this intestinal flora, that is, to improve the balance of the population in the intestinal flora to a more favorable one.

[0003] For example, Patent Document 1 discloses a composition for improving the diversity of intestinal flora by using a combination of oligosaccharides other than chitin oligosaccharides and dietary fiber as three or more types of indigestible carbohydrate raw materials in order to improve the diversity of intestinal flora. However, the effect of the composition is still not sufficient to meet the above needs. [Prior art documents] [Patent documents]

[0004] [Patent Document 1] JP 2020-178684 A Summary of the Invention [Problem to be solved by the invention]

[0005] The present invention is directed to solving the above problems, and its object is to provide a composition for improving the intestinal environment that can be easily ingested and further improves the balance of intestinal bacteria that make up the intestinal flora. [Means for solving the problem]

[0006] The present invention relates to a composition for improving intestinal environment, which contains dietary fiber and an anthocyanin compound.

[0007] In one embodiment, the dietary fiber is a water-soluble dietary fiber.

[0008] In a further embodiment, the water-soluble dietary fiber is at least one selected from the group consisting of guar gum decomposition products and acacia-derived dietary fiber.

[0009] In one embodiment, the anthocyanin-based compound is an anthocyanin.

[0010] In one embodiment, the anthocyanin compound is contained in the form of at least one plant extract selected from the group consisting of black currant fruit extract and bilberry fruit extract.

[0011] In one embodiment, the composition for improving intestinal environment of the present invention has a tablet or granule dosage form.

[0012] The present invention also relates to a composition for improving intestinal environment, which contains dietary fiber and a plant extract, and the plant extract is at least one selected from the group consisting of blackcurrant fruit extract and bilberry fruit extract.

[0013] The present invention also relates to an agent for enhancing the occupancy rate of bifidobacteria in intestinal flora, which contains dietary fiber and an anthocyanin compound. Effect of the Invention

[0014] According to the present invention, the balance of intestinal bacteria can be dramatically improved compared to the case where dietary fiber is ingested alone, and in particular, the occupancy rate of bifidobacteria in the intestinal bacterial flora can be increased. [Brief description of the drawings]

[0015] [Figure 1] 1 is a graph showing the results of a randomized, double-blind, placebo-controlled comparative study using each of the compositions of the Examples and Comparative Examples and a placebo composition, showing the occupancy rate of the Bifidobacterium genus in the intestinal bacterial flora. [Diagram 2] 1 is a graph showing the results of the diversity (number of species detected) of intestinal bacterial species that could be detected in a randomized, double-blind, placebo-controlled comparative study using each composition of the examples and comparative examples and a placebo composition. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0016] The present invention will be described in detail below.

[0017] (Composition for improving intestinal environment) The composition for improving intestinal environment of the present invention contains dietary fiber and anthocyanin compounds.

[0018] In the present invention, dietary fiber refers to a component that is not digested by the digestive enzymes of a living body (e.g., humans) or at least a portion of which is difficult to digest, and is contained, for example, in food and beverages or ingredients that constitute food and beverages (hereinafter sometimes referred to as "food and beverage ingredients").

[0019] The dietary fiber constituting the composition of the present invention is preferably water-soluble dietary fiber that is partially or completely soluble in water. Water-soluble dietary fiber has the property of gelling upon contact with water and adhering to the intestines of a living body (e.g., the intestinal walls of the small intestine and large intestine).

[0020] Examples of water-soluble dietary fibers include thickening polysaccharides such as guar gum, locust bean gum, tara gum, carob gum, tamarind seed gum, and gum arabic, glucomannan, pectin, hemicellulose, lignin, alginic acid, polydextrose, resistant dextrin, resistant starch, fucoidan, water-soluble soybean polysaccharides, pullulan, and acacia-derived dietary fiber, as well as decomposition products thereof (e.g., hydrolysates thereof). In the present invention, any combination of one or more of these dietary fibers may be used. Gum arabic, resistant dextrin, galactomannans such as fenugreek gum, guar gum, locust bean gum, and tara gum, resistant starch, water-soluble soybean polysaccharides, tamarind seed gum, pullulan, acacia-derived dietary fiber, and hydrolyzates thereof, and combinations thereof are preferred because they are easily assimilated by intestinal bacteria beneficial to the intestinal environment; galactomannans such as fenugreek gum, guar gum, locust bean gum, and tara gum, acacia-derived dietary fiber, and hydrolyzates thereof, and combinations thereof. are more preferred; galactomannans (e.g., fenugreek gum, guar gum, locust bean gum, etc.) having a ratio of galactose to mannose of 4 or less molecules of mannose to 1 molecule of galactose, acacia-derived dietary fiber, and hydrolyzates thereof, and combinations thereof are even more preferred; hydrolyzates of galactomannans and acacia-derived dietary fiber, and combinations thereof are even more preferred; and hydrolyzates of guar gum and acacia-derived dietary fiber, and combinations thereof are most preferred.

[0021] In addition, when the water-soluble dietary fiber is composed of two or more of the above-mentioned hydrolyzed products, the water-soluble dietary fiber may be obtained by hydrolyzing unhydrolyzed dietary fibers separately and then mixing them, or may be obtained by mixing unhydrolyzed dietary fibers and then hydrolyzing them all at once.

[0022] The molecular weight of the hydrolyzed product that can be used as water-soluble dietary fiber can be changed by changing the reaction time with the enzyme acting on the unhydrolyzed dietary fiber and other reaction conditions. The upper limit of the average molecular weight of the hydrolyzed product is preferably 100,000, more preferably 40,000, because it is easy to add the hydrolyzed product to food and drink ingredients. The lower limit of the average molecular weight of the hydrolyzed product is preferably 2,000, more preferably 5,000, because it is easy to assimilate the hydrolyzed product by intestinal bacteria that are beneficial to the intestinal environment.

[0023] The average molecular weight of such degradation products can be measured, for example, by measuring the molecular weight distribution using high performance liquid chromatography (e.g., a column manufactured by YMC Corporation (YMC-Pack Diol-120)) using polyethylene glycol (molecular weight: 2,000, 20,000, 100,000, etc.) as a marker.

[0024] In the present invention, the above-mentioned dietary fiber or water-soluble dietary fiber may be used as it is in a commercially available form. For example, examples of decomposition products of guar gum include Sunfiber (manufactured by Taiyo Kagaku Co., Ltd.), Guafiber (manufactured by Meiji Seika Kaisha, Ltd.), and Fiberon (manufactured by Dainippon Pharmaceutical Co., Ltd.). An example of indigestible dextrin includes Pinefiber (manufactured by Matsutani Chemical Industry Co., Ltd.). An example of low molecular weight sodium alginate includes Sorgin (manufactured by Kaigen Co., Ltd.). An example of water-soluble soybean polysaccharide includes Soya Five (manufactured by Fuji Oil Co., Ltd.).

[0025] In the present invention, anthocyanin compounds include anthocyanins and their analogs, and specific examples include anthocyanins, acylated compounds in which the sugar moiety constituting anthocyanin is bound to a fatty acid (e.g., acetic acid, malonic acid, malic acid, oxalic acid, succinic acid, quinic acid, tartaric acid, shikimic acid, p-hydroxybenzoic acid, cinnamic acid, p-coumaric acid, caffeic acid, ferulic acid, sinapic acid, vanillic acid, chlorogenic acid), and combinations thereof. Anthocyanin compounds have physiological activities such as antioxidant activity.

[0026] Anthocyanin is a group of compounds that are a type of polyphenol, and is a general term for glycosides with anthocyanidin as the aglycon. Specific examples of compounds included in anthocyanin include delphinidin-3-rutinoside, delphinidin-3-glucoside, delphinidin-3-galactoside, delphinidin-3-arabinoside, cyanidin-3-rutinoside, cyanidin-3-glucoside, cyanidin-3-sophoroside, cyanidin-3-galactoside, cyanidin-3-sophoroside-5-rhamnoside, cyanidin-3-sambubioside, cyanidin-3-sambubioside-5-rhamnoside, cyanidin-3-xylosyluloside, cyanidin-3-arabinoside, cyanidin-3-xylosylul ... These include ginseng-3-xyloside, cyanidin-3-(6''-malonoyl)glucoside, ginseng-3-dioxaloylglucoside, petunidin-3-glucoside, petunidin-3-galactoside, petunidin-3-rutinoside, petunidin-3-arabinoside, pelargonidin-3-rutinoside, peonidin-3-galactoside, peonidin-3-glucoside, peonidin-3-rutinoside, peonidin-3-arabinoside, malvidin-3-galactoside, malvidin-3-glucoside and malvidin-3-arabinoside. However, in the present invention, the compounds included in anthocyanin are not limited to the above aglycones and sugars.

[0027] In the present invention, the anthocyanin compound may be contained in the form of an extract obtained from a specific plant. Anthocyanin compounds are abundantly contained in fruits and vegetables such as grapes (particularly red grapes), black currants, and bilberries. For reasons such as easy availability and abundant content, the intestinal environment improving composition of the present invention may contain the anthocyanin compound in the form of black currant fruit extract, bilberry extract, or a combination thereof together with the dietary fiber.

[0028] The blending ratio of the dietary fiber and the anthocyanin compound in the intestinal environment improving composition of the present invention is not particularly limited, but may be, for example, 0.1 to 100 parts by mass, or 1 to 50 parts by mass, per 100 parts by mass of dietary fiber. When the anthocyanin compound is blended in an amount of 0.1 part by mass or more per 100 parts by mass of dietary fiber, the balance of intestinal bacteria constituting the intestinal flora is significantly improved compared to when dietary fiber is used alone.

[0029] The composition for improving intestinal environment of the present invention may contain other ingredients in addition to the above-mentioned dietary fiber and anthocyanin-based compounds. The other ingredients are not particularly limited, but may include, for example, excipients, binders, lubricants, disintegrants, surfactants, oils and fats, other additives, and combinations thereof.

[0030] Examples of excipients include lactose, lactose granulate, corn starch, L-cysteine, trehalose, maltitol, and sorbitol, and combinations thereof.

[0031] Examples of binders include crystalline cellulose, starch, sucrose, pregelatinized starch, hydroxypropyl cellulose, gelatin, powdered acacia, polyvinylpyrrolidone, pullulan, dextrin, cyclodextrin, methylcellulose, ethylcellulose, hydroxymethylcellulose, hydroxypropyl cellulose, hydroxypropylmethylcellulose, polyvinyl alcohol, and polyethylene glycol, and combinations thereof.

[0032] Examples of lubricants include calcium stearate, magnesium stearate, sodium stearyl fumarate, sucrose fatty acid esters, light anhydrous silicic acid, talc, and fine silicon dioxide, and combinations thereof.

[0033] Examples of the disintegrant include low-substituted hydroxypropyl cellulose, hydroxypropyl starch, partially pregelatinized starch, carboxymethyl cellulose, salts (sodium salts, calcium salts) and derivatives of carboxymethyl cellulose, and combinations thereof.

[0034] Examples of surfactants include amidobetaine-type amphoteric surfactants and imidazoline-type amphoteric surfactants, and combinations thereof.As a surfactant with high safety, it is preferable to use amphoteric surfactants derived from natural products.An example of an amphoteric surfactant derived from natural products is lecithin.

[0035] Examples of the oils and fats include rapeseed oil, jojoba oil, soybean oil, palm oil, coconut oil, and oils and fats subjected to hydrogenation treatment (so-called hydrogenation treatment) thereof, and combinations thereof.

[0036] Examples of other additives include foaming agents, colorants, flavoring agents, preservatives, antioxidants, UV absorbers, moisturizers, pH adjusters, fragrances, and flavor oils, and combinations thereof.

[0037] The contents of the above-mentioned other components in the intestinal environment-improving composition of the present invention are not particularly limited, and an appropriate amount can be appropriately selected by a person skilled in the art.

[0038] The composition for improving the intestinal environment of the present invention includes compositions that can be taken orally or through a tube by animals such as humans, pets, livestock, poultry, and farmed fish, and is used, for example, as food and drink, feed (feed), and medicines themselves or as one of their constituent materials. The composition of the present invention may also have any dosage form, and specific examples of the dosage form include powder, granule, pill, tablet, and liquid (including suspension, emulsion, etc.). It is preferable that the composition has any dosage form among powder, pill, tablet, and granule, because it can be easily taken orally.

[0039] When the composition for improving intestinal environment of the present invention is used as a food or beverage, examples of the food or beverage include general foods; supplements; health functional foods such as foods for specified health uses, foods with nutritional functions, and foods with functional claims; soft drinks; tea drinks; coffee drinks; processed milk; dairy drinks; soy milks; and alcoholic beverages.

[0040] The food and drink may contain food and drink ingredients and additives for food and drink in addition to the above-mentioned dietary fiber and anthocyanin compounds, and other components contained as necessary.

[0041] Food and beverage ingredients include, but are not limited to, plant extracts, vegetables, meat extracts, meats, fish meal, oils and fats, sugars, etc. Food and beverage additives include, but are not limited to, excipients (e.g., dextrin, cellulose, crystalline cellulose, methylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, sweeteners, colorants, preservatives, thickeners, stabilizers, gelling agents, pasting agents, antioxidants, colorants, bleaching agents, fungicides, yeast food, gum bases, kansui, bittering agents, enzymes, gloss agents, flavorings, acidulants, seasonings, coagulants, emulsifiers, pH adjusters, leavening agents, nutritional enhancers, solvents (e.g., water and ethanol), etc. The content of food and beverage ingredients and additives for food and beverage that can be contained in foods and beverages is not particularly limited, and an appropriate content can be appropriately selected by a person skilled in the art.

[0042] When the composition for improving intestinal environment of the present invention is used as a feed (a bait), examples of the feed (a bait) include pet food, formulated feed, and concentrated feed.

[0043] The feed may contain feed materials and feed additives in addition to the above-mentioned dietary fiber and anthocyanin compounds, and other components contained as necessary. The feed materials are not particularly limited, but examples thereof include grain flour, grass flour, eggshell flour, shell flour, fish meal, plant extracts, vegetables, meat extracts, meat, oils and fats, and sugars. The feed additives are not particularly limited, but examples thereof include preservatives, thickeners, stabilizers, gelling agents, pastes, antioxidants, fungicides, enzymes, gloss agents, flavorings, acidulants, emulsifiers, pH adjusters, leavening agents, nutritional enhancers, and solvents (e.g., water and ethanol). The content of the feed materials and feed additives that can be contained in the feed is not particularly limited, and an appropriate content can be appropriately selected by a person skilled in the art.

[0044] When the intestinal environment improving composition of the present invention is used as a medicine, the medicine may contain other medicinal ingredients or medicinal additives in addition to the above-mentioned dietary fiber and anthocyanin compounds, and other ingredients contained as necessary. Examples of other medicinal ingredients are not particularly limited, and include, for example, various medicinal ingredients that can be adopted as oral medicines. Examples of medicinal additives are not particularly limited, and include, for example, binders, disintegrants, lubricants, excipients, colorants, flavorings, surfactants, preservatives, antioxidants, ultraviolet absorbers, moisturizers, pH adjusters, etc. Specific examples of other additives that may be contained in pharmaceuticals include dextrin, cellulose, crystalline cellulose, methylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, powdered gum arabic, polyvinylpyrrolidone, polyethylene glycol, talc, silicon dioxide (e.g., light anhydrous silicic acid or hydrated silicon dioxide), magnesium stearate, stearic acid, stearyl alcohol, starches, hydroxypropyl starch, sodium carboxymethyl starch, powdered agar, ester oil, wax, higher fatty acid, higher alcohol, anionic surfactant, cationic surfactant, nonionic surfactant, amphoteric surfactant, polyhydric alcohol, water, ethanol, etc. The content of other medicinal ingredients and pharmaceutical additives that may be contained in pharmaceuticals is not particularly limited, and an appropriate content can be appropriately selected by a person skilled in the art.

[0045] In the intestinal environment improving composition of the present invention, both the dietary fiber and the anthocyanin compound are blended, so that, for example, when a human ingests the composition, bifidobacteria (e.g., microorganisms of the genus Bifidobacterium) present in the intestinal tract proliferate by assimilating the dietary fiber, while the anthocyanin compound reduces oxidative stress in the intestinal tract. As a result, the intestinal environment is exposed to such conditions, which makes it easier for bifidobacteria to proliferate and increases synergistically. As a result, the overall population of intestinal bacteria that make up the intestinal flora changes, and the balance of intestinal bacteria that make up the intestinal flora as a whole can be improved.

[0046] For this reason, a formulation containing the above-mentioned dietary fiber and anthocyanin-based compounds can also function as a composition for improving the occupancy rate of bifidobacteria in the intestinal flora (i.e., an agent for improving the occupancy rate of bifidobacteria in the intestinal flora).

[0047] In the present invention, the bifidobacteria whose occupancy rate in the intestinal bacterial flora can be improved are, for example, microorganisms of the genus Bifidobacterium.

[0048] Specific examples of microorganisms of the genus Bifidobacterium include Bifidobacterium longum, Bifidobacterium bifidum, Bifidobacterium adolescentis, Bifidobacterium infantis, Bifidobacterium breve, Bifidobacterium lactis, Bifidobacterium pseudolongum, Bifidobacterium animalis, Bifidobacterium actinocoloniiforme, Bifidobacterium aemilianum, and Bifidobacterium aerophyllum. aerophilum, Bifidobacterium aesculapii, Bifidobacterium angulatum, Bifidobacterium anseris, Bifidobacterium apri, Bifidobacterium aquikefiri, Bifidobacterium asteroides, Bifidobacterium avesanii, Bifidobacterium biavatii, Bifidobacterium bohemicum, Bifidobacterium bombi, Bifidobacterium boum, Bifidobacterium callimiconis callimiconis, B. callitrichidarum, B. callitrichos, B. canis, B. castoris, B. catenulatum, B. catulorum, B. cebidarum, B. coelinum, B.choerinum, Bifidobacterium choloepi, Bifidobacterium commune, Bifidobacterium coryneforme, Bifidobacterium criceti, Bifidobacterium cuniculi, Bifidobacterium denticolens, Bifidobacterium dentium, Bifidobacterium dolichotidis, Bifidobacterium erythrocebi, Bifidobacterium eulemuris, Bifidobacterium feucal, B. faecale, Bifidobacterium felsineum, Bifidobacterium gallicum, Bifidobacterium gallinarum, Bifidobacterium globosum, Bifidobacterium goeldii, Bifidobacterium hapali, Bifidobacterium imperatoris, Bifidobacterium indicum, Bifidobacterium inopinatum, Bifidobacterium italicum, Bifidobacterium jacchi, Bifidobacterium cassiwanohense, B. kashiwanohense), Bifidobacterium lemurum, Bifidobacterium leontopitheci, Bifidobacterium magnum, Bifidobacterium margollesii, Bifidobacterium merycicum, Bifidobacterium minimum, Bifidobacterium mongoliense, Bifidobacterium moraviensmoraviense, Bifidobacterium moukalabense, Bifidobacterium myosotis, Bifidobacterium oedipodis, Bifidobacterium olomucense, Bifidobacterium panos, Bifidobacterium parmae, Bifidobacterium parvulorum, Bifidobacterium porcinum, Bifidobacterium primatium, Bifidobacterium pseudocatenulatum, Bifidobacterium cyclaerophilum, B. psychraerophilum, Bifidobacterium pullorum, Bifidobacterium ramosum, Bifidobacterium reuteri, Bifidobacterium rousetti, Bifidobacterium ruminale, Bifidobacterium ruminantium, Bifidobacterium saeculare, Bifidobacterium saguini, Bifidobacterium samirii, Bifidobacterium scaligerum, Bifidobacterium scardovii, Bifidobacterium simiarum simiarum, B. stellenboschense, B. stercoris, B. subtile, B. suis, B. thermacidophilum, B. thermophilum, B. tibigranuliExamples of B. tibiigranuli, B. tissieri, B. tsurumiense, B. vansinderenii, B. vespertilionis, and B. xylocopae are B. tibiigranuli, B. tissieri, B. tsurumiense, B. vansinderenii, B. vespertilionis, and B. xylocopae.

[0049] The intake (or administration) amount of the intestinal environment improving composition and the intestinal bacterial flora bifidobacteria occupancy enhancer of the present invention is not particularly limited as it varies depending on the type, age, height, weight, daily food intake, etc. of the living body (human or animal) taking it, but for example, the daily intake amount for a healthy adult male can be, for example, 100 mg to 40,000 mg.

[0050] When ingested by humans, both the composition for improving intestinal environment and the agent for improving the bifidobacterial occupancy rate in the intestinal bacterial flora of the present invention are preferably taken within the range of the acceptable daily intake (ADI) or less of the above-mentioned dietary fiber and anthocyanin compounds, respectively. EXAMPLES

[0051] The present invention will now be described in further detail with reference to examples, but the present invention is not limited to these examples.

[0052] Each of the compositions (E1), (C1) to (C3) according to the formulation shown in Table 1 will be explained in detail below.

[0053] (Example 1: Composition (E1)) Composition (E1) was prepared by combining 100 parts by mass of guar gum hydrolyzate (molecular weight 2,000 to 100,000) and 1.25 parts by mass of anthocyanin derived from blackcurrant fruit (this part by mass of Blackcurrant Extract MJ manufactured by Morishita Jintan Co., Ltd. was used).

[0054] (Comparative Example 1: Composition (C1)) A composition (C1) was prepared by adjusting the daily intake amount of the guar gum hydrolyzate to the same amount as in Example 1, except that no anthocyanin derived from blackcurrant fruit was combined.

[0055] (Comparative Example 2: Composition (C2)) A composition (C2) was prepared by adjusting the daily intake amount of anthocyanins derived from blackcurrant fruit to the same amount as in Example 1, except that the guar gum hydrolyzate was not combined.

[0056] (Evaluation of Compositions (C1) to (C3) and (E1) by Randomized, Double-Blind, Placebo-Controlled Comparative Study) Male subjects in their twenties were randomly assigned to four groups: a control group (Group I; 23 subjects), a group taking the composition (C1) of Comparative Example 1 (Group II; 25 subjects), a group taking the composition (C2) of Comparative Example 2 (Group III; 26 subjects), and a group taking the composition (E1) of Example 1 (Group IV; 21 subjects). The subjects in the control group were made to take a composition (C3) (placebo composition (C3)) in which 100 parts by mass of maltodextrin was used instead of dietary fiber (guar gum hydrolyzate) and 1.25 parts by mass of maltitol was used instead of anthocyanin-based compounds (anthocyanins derived from blackcurrant fruit).

[0057] The intake period for these subjects was set to 4 weeks, and the subjects were instructed to take composition (C3) daily, composition (C1) daily, composition (C2) daily, and composition (E1) daily, at the daily intake amounts shown in Table 1. Group I took composition (C3), Group II took composition (C1), Group III took composition (C2), and Group IV took composition (E1).

[0058] [Table 1]

[0059] Feces were collected from each subject before and after the intake period (4 weeks). 16S rRNA metagenomic analysis was performed on the bacteria contained in each feces sample before and after intake to calculate the types and proportions of bacteria that make up the intestinal flora.

[0060] Specifically, the V3-V4 region of the 16S rRNA gene was amplified by PCR using the extracted bacterial DNA as a template. The following primers, each of which had a tail sequence for the second PCR, were used in this reaction: Forward primer 341F (5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3') (SEQ ID NO: 1) Reverse primer 805R (5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3') (SEQ ID NO:2).

[0061] The purified product was tagged by PCR using this PCR product as a template and primers with Illumina sequencing adapter and Index sequences (2nd PCR).

[0062] All the samples obtained were mixed at equal concentrations to prepare a library, and the base sequence of each sample was read using a next-generation sequencer (MiSeq; Illumina).

[0063] The obtained base sequences were then used to perform quality filtering, and then analyzed using a program dedicated to bacterial flora analysis (QIIME2 (http: / / qiime2.org / )). The occupancy rate of Bifidobacterium genus microorganisms that make up the intestinal flora of each subject, and the diversity of intestinal bacterial species (the number of detected species) were calculated. The results are shown in Figures 1 and 2.

[0064] As a result of the bacterial flora analysis, as shown in FIG. 1, in the subjects (Group I) who ingested the composition of Example 1 (E1), the occupancy rate of microorganisms of the genus Bifidobacterium before the start of intake (0w) increased to approximately two-fold (from 7.01% to 14.03%) four weeks after the start of intake (4w).

[0065] In contrast, in the subjects who ingested the composition of Comparative Example 1 (C1) (Group II) or the subjects who ingested the composition of Comparative Example 2 (C2) (Group III), no significant change in the occupancy rate was observed between before the start of intake (0w) and 4 weeks after the start of intake (4w).

[0066] Next, as shown in Figure 2, in the subjects (Group I) who ingested the composition (E1) of Example 1, the number of species of intestinal bacteria detected between before the start of intake (0w) and 4 weeks after the start of intake (4w) was significantly increased. A similar tendency was also confirmed in the subjects (Group III) who ingested the composition (C2) of Comparative Example 2.

[0067] In contrast, in the subjects (Group II) who ingested the composition of Comparative Example 1 (C1), no significant change was observed in the number of intestinal bacterial species detected between before the start of ingestion (0w) and four weeks after the start of ingestion (4w).

[0068] This shows that composition (E1) of Example 1, which combines guar gum hydrolysate (water-soluble dietary fiber) and anthocyanin (anthocyanin compound), can increase the occupancy rate of Bifidobacterium microorganisms that make up the intestinal flora of humans who ingest it, and effectively improve their intestinal environment. [Industrial Applicability]

[0069] The present invention is useful in technical fields such as the food field and the pharmaceutical field.

Claims

1. A composition for improving intestinal environment, comprising dietary fiber and anthocyanin compounds.

2. The composition for improving intestinal environment according to claim 1 , wherein the dietary fiber is water-soluble dietary fiber.

3. The composition for improving intestinal environment according to claim 2, wherein the water-soluble dietary fiber is at least one selected from the group consisting of guar gum hydrolysates and acacia-derived dietary fiber.

4. The composition for improving intestinal environment according to claim 1 , wherein the anthocyanin compound is anthocyanin.

5. The composition for improving intestinal environment according to claim 1, wherein the anthocyanin compound is contained in the form of at least one plant extract selected from the group consisting of black currant fruit extract and bilberry fruit extract.

6. The composition for improving intestinal environment according to claim 1 , which has the dosage form of a tablet or granule.

7. A composition for improving intestinal environment, comprising dietary fiber and a plant extract, the plant extract being at least one selected from the group consisting of blackcurrant fruit extract and bilberry fruit extract.

8. An agent for improving the occupancy rate of bifidobacteria in the intestinal flora, which contains dietary fiber and anthocyanin compounds.

Citation Information

Patent Citations

  • Composition for improving intestinal flora diversity

    JP2020178684A